Report Overview

The Canadian Brain Cancer market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period.

Brain cancers include primary brain tumours, which start in the brain and rarely spread to other parts of the body, and secondary tumours (or metastases), which are caused by cancers that began in another part of the body. There are more than 40 major types of brain tumours, which are grouped into two main types they are benign and malignant.

The mortality rate of brain cancer is more than 80% in Canada, every day in Canada it is estimated that 27 new primary brain tumours will be diagnosed, in 2020, an estimated 3,000 Canadians were diagnosed with brain and spinal cord cancer and 2,500 Canadians died from it. Among these, 1,700 men were diagnosed with brain and spinal cord cancer and 1,400 died from it &1,350 women were diagnosed with brain and spinal cord cancer and 1,050 died from it.



Market Drivers

The market size drivers for the growth of brain cancer diagnostics are expected to propel by technological developments, improvements in diagnostics machines. The rise in the number of cigarette smokers responsible for brain cancer has contributed to the market size. The population above 60 years of age forms the target demographic segment for this vertical, as this population subset is more prone to neurological conditions. The advancement of diagnostics equipment increases the lifespan of this demographic and improves the quality of life for those suffering from neurological conditions. Hence, the presence of a large geriatric population pool is considered a vital driver for this industry.